Vortrag am FONDS professionell KONGRESSiShares NASDAQ US Biotechnology UCITS ETF USD (Acc)
| MVD-Fonds Rating | EDA |
|---|---|
  | 75 |
ISIN: IE00BYXG2H39 | WKN: A2DWAW
KAG: BlackRock AM (IE)
NAV: 6,09 USD am 29.04.2025
Portfolio
Watchlist
KursalarmChart
Kennzahlen iShares NASDAQ US Biotechnology UCITS ETF USD (Acc)
| 1M | 6M | 1J | 3J | 5J | 10J | Beginn | |
| Performance | -1,17% | -11,32% | +0,18% | +13,00% | +8,15% | - | +22,13% |
| Volatilität | +41,49% | +23,87% | +20,40% | +21,22% | +22,20% | - | +23,52% |
| Sharpe Ratio | -0,39 | -0,99 | -0,10 | +0,09 | -0,03 | - | +0,02 |
| Bester Monat | - | +5,13% | +6,54% | +12,84% | +14,98% | - | +14,98% |
| Schl. Monat | - | -7,16% | -7,16% | -9,76% | -11,87% | - | -14,65% |
| Max. Verlust | -12,07% | -23,70% | -23,93% | -23,93% | -38,25% | - | -38,25% |
Monatsperformance iShares NASDAQ US Biotechnology UCITS ETF USD (Acc)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
| Januar | +5,13% | +0,34% | +3,47% | -11,87% | +6,22% |
| Februar | -0,21% | +1,07% | -6,43% | -3,99% | -2,31% |
| März | -6,01% | +0,08% | +1,29% | +4,30% | -4,25% |
| April | -1,17% | -6,06% | +1,47% | -9,76% | +2,94% |
| Mai | - | +5,84% | -2,63% | -1,19% | -1,96% |
| Juni | - | +3,32% | +0,14% | +1,05% | +8,03% |
| Juli | - | +6,54% | +1,28% | +4,09% | -0,23% |
| August | - | +0,86% | -0,28% | -1,00% | +4,13% |
| September | - | -2,28% | -3,88% | -2,39% | -4,88% |
| Oktober | - | -2,50% | -6,57% | +8,88% | -1,90% |
| November | - | -0,07% | +4,95% | +5,91% | -3,93% |
| Dezember | - | -7,16% | +12,84% | -2,98% | -1,27% |
| Gesamt | -2,55% | -0,97% | +4,22% | -10,52% | -0,40% |
Diese Fonds könnten Sie auch interessieren
Vergleichen Sie diese Fonds mit Ihrem ausgewähltem Fonds (iShares NASDAQ US Biotechnology UCITS ETF) oder suchen Sie weitere Top-Fonds zum Thema Aktien (ETF Aktien) USA in USD:
Fonds vergleichenWeitere ähnliche Fonds